StockNews.com initiated coverage on shares of Navidea Biopharmaceuticals (NYSEAMERICAN:NAVB – Free Report) in a research report sent to investors on Tuesday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Navidea Biopharmaceuticals Stock Performance Shares of NYSEAMERICAN:NAVB opened at $0.09 on Tuesday. The business’s 50 day simple moving average is $0.13 and its […]
StockNews.com assumed coverage on shares of Navidea Biopharmaceuticals (NYSEAMERICAN:NAVB – Get Rating) in a report released on Friday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Navidea Biopharmaceuticals Stock Performance NYSEAMERICAN:NAVB opened at $0.10 on Friday. The stock’s fifty day moving average price is $0.15 and its two-hundred day moving average […]
StockNews.com assumed coverage on shares of Navidea Biopharmaceuticals (NYSEAMERICAN:NAVB – Get Rating) in a research report released on Wednesday. The firm issued a sell rating on the biopharmaceutical company’s stock. Navidea Biopharmaceuticals Stock Performance Shares of NYSEAMERICAN:NAVB opened at $0.10 on Wednesday. The stock has a 50 day moving average of $0.15 and a 200 […]
StockNews.com assumed coverage on shares of Navidea Biopharmaceuticals (NYSEAMERICAN:NAVB – Get Rating) in a research report sent to investors on Tuesday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Navidea Biopharmaceuticals Price Performance NYSEAMERICAN:NAVB opened at $0.10 on Tuesday. Navidea Biopharmaceuticals has a 52 week low of $0.07 and a 52 […]
StockNews.com started coverage on shares of Navidea Biopharmaceuticals (NYSEAMERICAN:NAVB – Get Rating) in a research report released on Tuesday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Navidea Biopharmaceuticals Price Performance NAVB stock opened at $0.10 on Tuesday. The company has a fifty day moving average price of $0.16 and a […]